Barrett's-related esophageal cancer: Has the final hurdle been cleared, now paving the way for human chemoprevention trials?

This publication has 36 references indexed in Scilit:

• A multicenter, partially blinded, randomised study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in Barrett's esophagus (BE): Results of 6-month follow-up
  Gastroenterology, 2001
• Progression of Barretl's esophagus to high grade dysplasia and cancer: Preliminary results of the BEST (Barrett's esophagus study) trial
  Gastroenterology, 2001
• Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
  JAMA, 2000
• Expression of cyclo-oxygenase 2 (COX-2) in Barrett's esophagus, dysplasia and adenocarcinoma
  Gastroenterology, 2000
• Selective inhibition of cyclooxygenase-2 inhibits growth and induces apoptosis in human esophageal adenocarcinoma cells
  Gastroenterology, 2000
• Perspectives on endoscopic eradication of Barrett's esophagus: Who are appropriate candidates and what is the best method?
  Gastrointestinal Endoscopy, 1999
• Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results
  Gastrointestinal Endoscopy, 1996
• Barrett's esophagus: Does an antireflux procedure reduce the need for endoscopic surveillance?
  The Journal of Thoracic and Cardiovascular Surgery, 1996
• Conservative treatmentversus antireflux surgery in Barrett's oesophagus: Long-term results of a prospective study
  British Journal of Surgery, 1996
• Regression of Barrett's esophagus by laser ablation in an anacid environment
  Digestive Diseases and Sciences, 1993